<http://schema.org/articleBody>
" Scientists believe that an experimental drug may be beneficial for people with Alzheimer&amp;#039;s disease, the most common form of dementia. The drug, CPHPC, targets and removes from the blood a protein called serum amyloid P component (SAP), which has previously been identified as a possible target for Alzheimer&amp;#039;s disease therapies. CPHPC has now been shown to also remove SAP from the brains of patients with Alzheimer&amp;#039;s disease. Five individuals received the experimental drug for three months and researchers found that they demonstrated a &amp;#039;remarkable&amp;#039; reduction in SAP in the brain. Professor Martin Rossor, from University College London&amp;#039;s Dementia Research Centre, commented: &amp;#039;The safety of CPHPC, together with the novel action of the drug in removing SAP from the brain, is very encouraging.&amp;#039; Lead researcher Professor Mark Pepys added that the findings &amp;#039;strongly support further clinical studies to see whether longer-term treatment with CPHPC protects against the inexorable mental decline in patients with Alzheimer&amp;#039;s disease&amp;#039;. The study was part-funded by the Alzheimer&amp;#039;s Research Trust, which has welcomed the development but urged caution. Chief executive Rebecca Wood expressed &amp;#039;cautious optimism&amp;#039; and said that larger and longer-term studies are needed into the drug. "^^<http://www.w3.org/2001/XMLSchema#string>
<http://www.netdoctor.co.uk/healthy-living/news/a17991/new-drug-removes-unwanted-protein-from-alzheimers-brain/>